NCT06640257View on ClinicalTrials.gov

A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis

PHASE3RecruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

November 4, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

June 30, 2026

Conditions

Psoriatic Arthritis

Interventions

DRUG

SHR-1314 injection

SHR-1314 injection

DRUG

Placebo

Placebo

Trial Locations (1)

200433

RECRUITING

Huashan Hospital of the Shanghai FuDan University, Shanghai

All Listed Sponsors

lead

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

INDUSTRY